Radiation Oncology
Expert insights on radiation treatment planning, techniques, toxicity management, and multimodal cancer care.
Recent Discussions
Is there any advantage to proton beam therapy in a locally recurrent anal carcinoma, which has already been treated with concurrent chemo RT as well as APR for relapse?
Even with a local recurrence, patients’ life expectancy can be relatively long, which often introduces the question of repeating radiation treatment. Although this option must be balanced with the potential toxicities and consequences of re-treatment, the possible morbidity from tumor progression is...
Do you recommend adjuvant RT to patients with non-ATM genetic mutations (e.g. BRCA, NF) who elect to have lumpectomy and are otherwise PRIME II/CALGB candidates for RT omission (i.e. low risk disease characteristics: strongly ER+, <1cm, grade 1-2, no LVI, widely negative margins, and committed to endocrine therapy)?
Again, as in the previous hypothetical, this patient is otherwise well-qualified and has chosen to forego surgical prophylaxis. Is she eligible for PBI? If not, she should have whole-breast?… And perhaps contralateral “radiation prophylaxis”? I don’t believe so. In the studies you referenced, we did...
What dose/fractionation would you recommend for primary aneurysmal bone cyst of spine after a subtotal resection?
See the articles below: Mendenhall et al., PMID 16755186 Zhu et al., PMID 26165419
How do you manage incidentally identified pituitary lesions on brain imaging?
Pituitary lesions are among the most common incidentalomas seen on brain MRIs. Various studies cite numbers as high as 10- >30% for pituitary lesions found incidentally on brain imaging, with the higher incidence rates emerging in the era of high-resolution MRIs. In pediatric neurology/neuro-oncolog...
Do you ever consider a third course of CNS radiation to the same area for an in-field recurrence?
I’m assuming this is for brain metastases? If so, would be helpful to know how long and interval time of the first and second RT treatments. Would discuss this at our brain mets tumor board. Any particular reason why not surgical or LITT candidate? If this patient has a good KPS, no or minimal extra...
Would you offer partial breast radiation for bilateral DCIS?
Yes, would offer APBI
Would you recommend PMRT to a clinically node positive (biopsy proven axillary node and indeterminate single IMN node) BRCA positive patient with multiple medical co-morbidities including scleroderma and ILD who is treated with neoadjuvant chemotherapy (NAC) and mastectomy who converts to ypT0/ypN0?
Given pathological complete response and comorbidities, I would favor the omission of RT. While not a clear B-51 case, if you think IM was involved, given the totality of the situation omission is how I would go as long as post-chemo MRI showed stable or smaller IM node.
Would you prefer SBRT or fractionated radiation for a sacral peripheral nerve sheath tumor?
For a sacral peripheral nerve sheath tumor, I would favor SBRT (Stereotactic Body Radiation Therapy) over fractionated radiation due to its ability to deliver a high dose of radiation precisely to the tumor while minimizing damage to surrounding healthy tissues, especially in a sensitive area like t...
What is your approach to a patient with incidentally found DCIS or invasive disease after a breast reduction?
Typically, in these cases I will give standard whole breast irradiation (40/15). I have not boosted as it's often unclear where the boost target is.
Can radiation to the breast be given in the setting of prior radiation for Hodgkin's lymphoma?
Based on previous dose and volume (as most people are getting ISRT and between 20-30 Gy), either whole breast or partial breast RT are usually options. One concern I have is the increase IBTR which is most likely new primary in these patients because of prior RT exposure (akin to BRCA mutation).